Blast at San Francisco Amgen lab injures 2

Emily Mullin Two people were injured in an explosion at Amgen's South San Francisco research lab earlier this week, according to several reports. The blast was the second to occur ...

Adcock forges ahead with its African expansion while CFR deal stalls

Carly Helfand Adcock Ingram's takeover by Chile's CFR Pharmaceuticals may be stalled, but that hasn't stopped the South African drugmaker from moving forward with its ...

J&J Innovation settles into a fast-paced global swirl of dealmaking

John Carroll Over the last 6 months or so, Johnson & Johnson's ($ JNJ) big new innovation initiative has been bringing together deal teams in key R&D hot spots around the ...

Compounders start to sign up for FDA oversight

Eric Palmer There are about 3,000 compounding pharmacies in the U.S. that can whip up sterile injectable drugs. Fourteen of those have signed up to be regulated by the FDA. Four of ...

Billionaire backs new program for a pioneering Alzheimer’s vaccine from AC Immune

John Carroll German billionaire Dietmar Hopp is adding to his multimillion-dollar wager on AC Immune, the Swiss biotech that is playing a key role in some high-profile Alzheimer's ...

Former Bristol-Myers R&D chief signs on at VC firm

Tracy Staton Sigal is joining New Enterprise Associates, where former MedImmune CEO David Mott has been leading the healthcare crew. FiercePharma News

AbbVie amps up ‘armed antibody’ deal with Seattle Genetics to the tune of $255M

Tracy Staton Whatever AbbVie learned in the first stages of its collaboration with Seattle Genetics on antibody-drug conjugates must have seriously whetted the pharma company's ...

UPDATED: FDA OKs AstraZeneca’s long-delayed diabetes drug dapagliflozin

John Carroll The FDA has handed AstraZeneca a green light to begin marketing dapagliflozin, its long-delayed SGLT2 diabetes drug, which will now try to defy ...

Indian drugmakers grab big share of U.K. pharma market

Tracy Staton In the U.K., drugs produced in India are almost as common as those made in Britain, a new report from the Medicines and Healthcare Products Regulatory Agency says. FiercePharma ...

Top cancer research institutions split $540M windfall

John Carroll Memorial Sloan-Kettering Cancer Center in New York now has an extra $ 90 million to devote to cancer immunotherapy research.  FierceBiotech News

GE beefs up life sciences division with $1.06B Thermo Fisher deal

John Carroll GE Healthcare is expanding its footprint in the life sciences industry, snapping up the cell culture, gene modulation and magnetic bead business of Thermo Fisher Scientific ...

Is the audience listening? FDA wants to spy on social media to find out

Tracy Staton Do people listen to the FDA? The agency wants to know–and it's planning to track online chatter to find out. FiercePharma News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS